Results 41 to 50 of about 818,749 (164)
Background: Imipenem-relebactam is a new β-lactam and β-lactamase inhibitor combination to treat carbapenem-resistant gram-negative bacteria infections. However, difference in carbapenem resistant mechanisms existed with geographic variations. Objective:
Tsung-Ying Yang +9 more
doaj +1 more source
In recent years, carbapenem-resistant Enterobacteriaceae has become endemic in many countries. Because of limited treatment options, the abandoned “old antibiotics”, polymyxins, have been reintroduced to the clinic.
Wentao Ni +6 more
doaj +1 more source
Objective To evaluate the performance of modified carbapenem inactivation method (mCIM) and EDTA carbapenem inactivation method (eCIM) in detection of carbapenemase in Enterobacteriaceae Bateremia.
WANG Yonghong +5 more
doaj +1 more source
Introduction Occurrence of colistin-resistant Enterobacteriaceae in response to the unregulated use of this antibiotic has been documented. This study reports an investigation of colistin resistance rates among carbapenem-resistant enterobacterial ...
Hadir A. El-Mahallawy +3 more
doaj +1 more source
Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children [PDF]
AbstractInfections due to carbapenem-resistant Enterobacteriaceae (CRE) are increasingly prevalent in children and are associated with poor clinical outcomes. Optimal treatment strategies for CRE infections continue to evolve. A lack of pediatric-specific comparative effectiveness data, uncertain pediatric dosing regimens for several agents, and a ...
Kathleen, Chiotos +3 more
openaire +2 more sources
Background: Carbapenem-resistant Enterobacteriaceae (CRE) is of utmost clinical importance because they challenge the armamentarium of the treating clinicians, hampering current treatment strategies.
Puneet Bhatt +5 more
doaj +1 more source
OXA-48-producing Enterobacteriaceae in North of Morocco: Data from regional hospital of Tangier
Introduction: This is a three-year retro-prospective study aimed at assessing the prevalence of carbapenem-resistant Enterobacteriaceae and to study three-year retrospective study aimed at determining the prevalence of carbapenem-resistant ...
Younes Mahrach +4 more
doaj +1 more source
Colistin resistance involving Gram-negative bacilli infections is a challenge for health institutions around of the world. Carbapenem-resistance among these isolates makes colistin the last therapeutic option for this treatment. Colistin resistance among
Flávia Rossi +5 more
doaj +1 more source
This paper highlights a concerning scenario of environmental contamination by multidrug‐resistant bacteria, underscoring the need for integrated surveillance and control strategies to address antimicrobial resistance in aquatic environments within the context of One Health.
Francisco Lucas de Amorim Nascimento +13 more
wiley +1 more source
Carbapenemase-producing Enterobacteriaceae: A diagnostic, epidemiological and therapeutic challenge
The global spread of carbapenemase-producing Enterobacteriaceae (CPE) has become a public health problem. Not all CPE are resistant to carbapenems creating a diagnostic and therapeutic challenge.
María Virginia Villegas
doaj +1 more source

